Thank you Mavenwood,
ALRX has more than one product in the pipeline. The main focus is Indaflex from a Cypress viewpoint. I like that they want to tweak the study for best results. For the longs in here I think we will take the large reward later. How much later I guess is in the hands of Cyress, Michael Lee and company. Don't forget they just put this deal together it will take some transition time.
0 members recommend this.
